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Introduction: Histone H3 lysine 27 trimethylation (H3K27me3) and H3 lysine 36 trimethylation (H3K36me3) are
important epigenetic modifications correlated with transcription repression and activation, respectively. These two
opposing modifications rarely co-exist in the same H3 polypeptide. However, a small but significant amount of H3
tails are modified with 5 methyl groups on K27 and K36 in mouse embryonic stem cells (mESCs) and it is unclear
how the trimethylation is distributed on K27 or K36.
Methods: A label-free, bottom-up mass spectrum method, named specific ions of isobaric modification
chromatogram (SIMC), was established to quantify the relative abundance of K27me2-K36me3 and K27me3-K36me2
in the same histone H3 tail.
Results: By using this method, we demonstrated that the H3K27me3-K36me2 comprises about 85 % of the penta-
methylated H3 tails at K27 and K36 in mESCs. Upon mESC differentiation, the abundance of H3K27me3-K36me2
significantly decreased, while the level of H3K27me2-K36me3 remains unchanged.
Conclusion: Our study not only revealed the cis-existence of H3K27me3-K36me2 in mESCs, but also suggested that
this combinatorial histone modification may assume a specific regulatory function during differentiation.Introduction
Histone methylation is a complex modification that reg-
ulates transcription and chromatin dynamics [1–3].
Methylation can occur at lysine and arginine residues in
histone proteins. Each lysine residue can have three
states of methylation, having one (mono), two (di), or
three (tri) methyl groups covalently attached to the
amine group of the lysine side chain, and the arginine
residue can be monomethylated, or symmetrically or
asymmetrically dimethylated [4–6]. Depending on the
specific residues and modification states, histone methy-
lation can repress or activate transcription [2, 7]. For ex-
ample, histone H3 lysine 27 trimethylation (H3K27me3)* Correspondence: mao.hailei@zs-hospital.sh.cn; cdchen@sibcb.ac.cn
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histone H3 lysine 36 trimethylation (H3K36me3) is asso-
ciated with transcriptional activation [3, 8, 9].
Genome-wide chromatin immunoprecipitation sequen-
cing (ChIP-Seq) experiments revealed that higher methy-
lation states of H3K27 (H3K27me2/3) and H3K36
(H3K36me2/3) rarely colocalized at the same genomic
locus, consistent with their opposing functions [8, 9].
However, it was recently reported that two polycomb-
like proteins, PHF1 and PHF19, can target polycomb
repressive complex 2 (PRC2) to catalyze H3K27me3
through binding to H3K36me3 in a subset of developmen-
tal genes in embryonic stem cells (ESCs) [10], indicating
an important regulatory interplay between these two op-
posing marks. In fact, H3K27me2/3 and H3K36me2 are
found colocalized in the same nucleosome in ESCs, mouse
embryonic fibroblast (MEF) cells, and HeLa cells [11].
These results suggest that the higher methylation states at
H3K27 and H3K36 residues can form a combinatorial
modification cis-existing at the same H3 and may alsodistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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though histone H3 peptide containing both H3K27 and
H3K36 sites with five methyl groups was also detected by
mass spectrometry (MS) [11, 12], the assignment of the
five methyl groups in H3K27 and H3K36 in ESCs and
during differentiation is currently unknown.
Quantification of histone methylations can be achieved
by a bottom-up MS strategy [13, 14]. In this approach,
individual or intact histones are digested by site-specific
proteases to generate a peptide containing a modified
residue of interest and the amount of peptide is quanti-
fied at the MS level. However, the current digestion
methods cannot always generate a peptide with only one
modification, because histones are densely modified on
their short N-terminal tails [15, 16]. For example, trypsin
or Arg-C digestion can produce a peptide from H3K27
to H3R40 (K27-R40) that contains K27 and K36, both of
which are subject to methylation. If H3K27-R40 frag-
ments contain five methyl groups (me5), there are two
possible patterns: K27me2-K36me3 and K27me3-
K36me2. Although the level of H3K27-R40 with a cer-
tain number of methyl groups can be quantified by se-
lected ion chromatogram (SIC) at the MS level, whether
the methyls are on K27 or K36 cannot be determined.
Fragments with the same number of modified groups
but different patterns of distribution are called isobari-
cally modified peptides [14, 15].
Quantification of isobarically methylated H3K27-R40
peptides has been attempted by increasing the elution
time in reversed phase high-performance liquid chroma-
tography (RP-HPLC) [15]. Using this method, several
isobarically modified peptides were artificially divided
into different fractions by liquid chromatography (LC)
and quantified. Since each isoform of the isobarically
modified peptides behaves virtually identically in RP-
HPLC [14], the assignment of the isoform is subjective
and therefore the quantification is unreliable [15].
Another method to quantify isobarically methylated
H3K27-R40 peptides is by propionic anhydride labeling
[11, 12, 14]. Propionic anhydride is used to add propio-
nyl group to the N-terminal, unmodified and mono-
methylated lysines, and then trypsin is used to produce
the target H3K27-R40 peptides. For some isobarically
modified peptides, the propionylated isoforms will have
different RP-HPLC retention times and masses, which
can be subjected to separation and quantification by SIC
at the MS level. However, this technology cannot quan-
tify all forms of isobarically modified peptides; for ex-
ample, H3K27me2-K36me3 and H3K27me3-K36me2
cannot be distinguished [11, 12, 14]. Effective methods
for systemic quantification of the isobarically modified
peptides are therefore still lacking.
In this study, we developed a label-free, bottom-up
MS method that can quantify the relative abundance ofK27me2-K36me3 and K27me3-K36me2 in the same his-
tone H3 tail. Using this method, the specific ions of iso-
baric modification chromatogram (SIMC), H3K27me3-
K36me2 was shown to be the major form, comprising
about 85 % of pentamethylated H3 tails at K27 and K36
sites in mouse embryonic stem cells (mESCs). Moreover,
the abundance of H3K27me3-K36me2 significantly de-
creased upon mESC differentiation, suggesting a specific
regulatory function in the process.
Methods
LC-MS/MS for synthetic isobarically methylated histone
peptides
Two synthetic isobarically methylated peptides of
K27SAPATGGVKKPHR40me5 (K27-R40me5) from histone
H3.1 or H3.2 with a purity of more than 90 %, S1 (K27me2-
K36me3) and S2 (K27me3-K36me2), were diluted to the
same concentration. The two peptides were then mixed in
weight ratios of 3:1 (M1), 1:1 (M2), 1:3 (M3), and 1:6 (M4).
The individual peptide and their mixtures including 75 ng
H3K27-R40me5 peptides were analyzed by LC-tandem mass
spectrometry (MS/MS) using a Waters nanoAcquity UPLC
system (Waters, Milford, Massachusetts, USA) interfaced to
a LTQ-Orbitrap instrument (ThermoFisher Scientific, Bre-
men, Germany) and run in a positive ion mode. The nanoli-
ter flow LC was operated in a CapTrap (MICHROM,
Bioresources, Inc., Auburn, California, USA) and one follow-
ing analytical column (75 μm×15 cm) packed with C18
reverse-phase material (Ultimate C18, 100 Å, 3 μm spherical
particles). Solvent A was double-distilled water (ddH2O)
with 0.1 % formic acid, and solvent B was acetonitrile (Ther-
moFisher Scientific, Bremen, Germany) with 0.1 % formic
acid. Samples were injected into solvent A at a flow rate
of 300 nl/minute. Peptides were separated with a gradient
of 5–35 % solvent B from 0–25 minutes. The full-scan MS
spectra were acquired in Orbitrap with a resolution of
60,000 for mass-to-charge ratio (m/z) and 400 full width at
half maximum (FWHM). The full MS mass range was
300–1600, AGC target 1,000,000, and maximum injection
time 500 milliseconds. The three most intense ions with a
parent m/z value of K27-R40me5 carrying charge 3+
(501.9755) were isolated for fragmentation in the Orbitrap
with a resolution of 15,000 (high resolution) and LTQ (low
resolution) using collision-induced dissociation (CID; with
a normalized collision energy of 35 %, and an isolation
window of 2.00 units), respectively. The dynamic exclusion
time was not enabled.
LC-MS/MS for tryptic synthetic isobarically methylated
histone peptides
Two synthetic isobarically methylated peptides of
L20ATKAARKSAPATGGVKKPHRYRPGTVALREIR52me5
(L20-R52me5) from histone H3.1 or H3.2 with a purity of
more than 90 %, L1 (K27me2-K36me3) and L2 (K27me3-
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long peptides were mixed in weight ratios of 3:1, 1:1, 1:3, and
1:6, and samples with a total of 2.5 μg mixture were digested
with trypsin (V511C; Promega, Madison, Wisconsin, USA)
at a substrate/enzyme ratio of 200:1 at 37 °C for 20, 40, and
120 minutes, respectively. The tryptic samples including
150 ng H3L20-R52me5 peptides were analyzed by LC-MS/
MS using the same LTQ-Orbitrap instrument (Thermo-
Fisher Scientific), LC gradient, and MS method.
Culturing of mESCs and differentiation
mESCs (SCR012, strain 129/S6/SvEv, MILLIPORE,
Billerica, Massachusetts, USA) were maintained on mi-
tomycin C-treated MEF feeders in Dulbecco’s modified
Eagle’s medium supplemented with 16 % ESC-tested
fetal bovine serum (Hyclone, Logan, Utah, USA),
0.15 mM α-monothioglycerol, 2 mML-glutamine, 0.1 mM
nonessential amino acid, 10 mM HEPES (Sigma-Aldrich,
St. Louis, Missouri, USA), 1000 U/ml recombinant leukemia
inhibitory factor (LIF, Chemicon, Temecula, California,
USA), and 100 U/ml penicillin/streptomycin.
For in-vitro differentiation, 2 × 106 feeder-depleted
ESCs were aggregated in 10 cm ultra-low attachment
plates (Corning, New York, USA) in embryonic stem dif-
ferentiation medium without LIF. Embryoid bodies were
collected at day 0 (D0), day 2 (D2), and day 4 (D4).
Quantitative real-time PCR
RNA was isolated from 1 × 106 ESCs or 200 embryonic
bodies using the RNeasy Plus kit (QIAGEN, Duesseldorf,
Germany). First-strand cDNA synthesis was made with
the SuperScript III First-Strand Synthesis SuperMix
(Invitrogen, Carlsbad, California, USA). The relative
expression of each gene was determined by normalizing
to Gapdh mRNA level. Quantitative RT-PCR was per-
formed with SYBR Green Master Mix (Bio-Rad,
Hercules, California, USA) on an Eppendorf Mastercycler
ep realplex2 s (Eppendorf, Hamburg, Germany). Primers
for tested genes are from [17, 18].
LC-MS/MS for tryptic histone peptides from mESCs
Intact histones were extracted from mESCs using a con-
ventional acid extraction method [19]. A total of 100 μg
freeze-dried histones were digested with trypsin (V511C;
Promega) at a substrate/enzyme ratio of 200:1 for 40 mi-
nutes at 37 °C. Tryptic peptides were analyzed using a
Shimadzu HPLC system (Shimadzu, Kyoto, Japan) inter-
faced to an LTQ-Orbitrap XL instrument run in positive
ion mode. The LC was operated in a 25 cm analytical
column (1 mm inner diameter, ZORBAX 300SB-C18,
5 μm, 300 Å; Agilent, Palo Alto, California, USA) with a
1.7 cm precolumn (1 mm inner diameter, ZORBAX Sta-
blebond, C18, 5 μm, 300 Å; Agilent). Here, Solvent A
was 5 % acetonitrile (Fisher Scientific) with 0.05 % tri-
fluoroacetic acid (TFA) in ddH2O, and solvent B was 90 %acetonitrile with 0.05 % TFA. A total of 20 μg tryptic sam-
ple was injected into solvent A at a flow rate of 50 μl/
minute. The gradient was 5–45 % solvent B from 5 to
45 minutes. The mass spectrometer was operated in the
data-dependent mode to automatically switch between
MS and MS/MS acquisition. The full-scan MS spectra
were acquired in Orbitrap with a resolution of 60,000
FWHM. The full MS mass range was 250–2000, AGC tar-
get 1,000,000, and maximum injection time 500 millisec-
onds. The five most intensive ions with a parent 3+ charge
precursor of K27-R40me5 (501.9755) were isolated for
fragmentation in the LTQ using CID (normalized collision
energy 35 %). Singly charged precursor ions were ex-
cluded, and the dynamic exclusion time was not enabled.
Western blotting
To examine the global level of H3K27me3 in ES cells at D0,
D2, and D4, 1 μg extracted bulk histones from these cells
were resolved by 15 % SDS-PAGE respectively. H3K27me3
specific antibody (07–449; Upstate Biotechnology, Lake
Placid, New York, USA) was first used, and then striped for
H3 antibody (ab1791; Abcam, Cambridge, UK) detection as
the loading control.
Quantification by SIMC
Database searching for MS/MS spectra was performed
against histone sequences in the UniProt database (20 January
2009) with 29 entries using SEQUEST within Bioworks
3.3.1 SP1 software (ThermoFisher Scientific) [20]. Five miss-
ing cleavages were allowed and mass tolerance of 20 ppm
was set for precursor ions. Variable modifications included
protein N-terminal acetylation, (mono, di, and tri)methyla-
tion and acetylation of lysine, (mono and di)methylation of
arginine, phosphorylation of serine and threonine, and oxi-
dation of methionine. Initial acceptance criteria for the
match required a mass error of precursor less than 0.01 Da,
and the search results from peptides of interest were then
manually verified using Bioworks Browser software.
The quantification method for SIMC is the following:
extract the matched MS/MS spectra from the raw data
using Xcalibur 2.0.7 software (ThermoFisher Scientific);
calculate the theoretical m/z values of a series of specific y
ions for individual isobarically modified peptide according
to the monoisotopic mass from MS-Product (UCSF, San
Francisco, California, USA); search for matched y ions from
the MS/MS spectral data according to the theoretical values
with a mass tolerance of 10 ppm for high-resolution
Orbitrap data or 0.4 Da for LTQ data, and select one with
the smallest mass error for a specific y ion (there is no
signal-to-noise threshold for the selection of ions); sum up
the intensity of all the matched y2+ ions specific for an
isoform, which represents the quantity of the isoform; and
calculate the percentage of each isoform based on the
quantity of every isoform. The fragments with the minimal
mass errors were selected and their information was listed
in a table including matched type of isobaric modification,
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sity, m/z value, and mass error.
For quantification of H3K27-R40me5 and H3D123-
R128 peptides, conventional SIC was used. The SIC values
of modified peptides were obtained by summing up indi-
vidual SIC values from all charge states: 1–4+ for H3K27-
R40me5 peptides, and 1–2+ for H3D123-R128 peptides
with a mass tolerance of 10 ppm for Orbitrap data. By
multiplying the total amount of the H3K27-R40me5 and
the constituent percentage of each isoform determined by
SIMC, we quantified the abundance of K27me2-K36me3
and K27me3-K36me2 isoforms. The abundances of
K27me2-K36me3 and K27me3-K36me2 isoforms were
normalized to the SIC values of H3D123-R128 peptides to
acquire their relative abundance. All experiments in this
study were repeated three times and the deviation number
was the standard deviation (SD). Data are expressed as
mean ± SD. Comparisons involving three mESC groups
were performed with one-way analysis of variance.
Results and discussion
Comigration of H3K27me3-K36me2 and H3K27me2-
K36me3-containing K27-R40 peptides in RP-HPLC
RP-HPLC was applied to separate H3K27me3-K36me2
and H3K27me2-K36me3-containing peptides since they
are isobarically modified peptides with the same molecularFig. 1 Characteristics of H3K27me3-K36me2 and H3K27me2-K36me3-contain
histone H3K27-R40 peptides and their specific ions. b Comigration of H3K27m
Two synthetic isobarically modified peptides of H3K27-R40, S1 (K27me2-K36m
(1:3), and M4 (1:6), were subjected to LC-MS analysis. c Strongest tandem mas
by each isoform were marked with different colors (K27me2-K36me3, red; K27
types of y11–y132+ ions in the single spectrum. d The intensity of two types o
M2 was displayed as a chromatographic profile. Quantification was based onweight. Two peptides of H3K27-R40me5, S1 (K27me2-
K36me3) and S2 (K27me3-K36me2) (Fig. 1a), mimicry of
the enzymatic products of histone H3, were synthesized
and tested by RP-HPLC. When each peptide was exam-
ined by LC-MS/MS, the retention time of S1 was around
13.58 minutes and of S2 was around 13.76 minutes
(Fig. 1b), indicating that both peptides had similar chro-
matographic behavior. To examine whether two peptides
coelute in mixtures, four different ratios of two peptides
(M1–M4) were mixed and examined under the same ex-
perimental conditions. Despite the four weight ratios of
the peptides in the mixture, only one single peak with a
similar retention time to the pure forms was observed at
around 13.34–13.52 minutes (Fig. 1b). These results indi-
cated that H3K27me2-K36me3 and H3K27me3-K36me2-
containing peptides were coeluted in RP-HPLC, and could
not be separated and quantified for the same molecular
weight at the first MS level, which was consistent with
published data [12, 21, 22].
Examination of specific ions for H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides
At the MS level, H3K27me3-K36me2 and H3K27me2-
K36me3-containing peptides produced the same 1–4+
precursor ions, namely no different intensity distribution
between individual and mixed peptides (predominantly 3+ing peptides. a Schematic representation of isobaric pentamethylation of
e3-K36me2 and H3K27me2-K36me3-containing peptides on RP-HPLC.
e3) and S2 (K27me3-K36me2), and their mixtures, M1 (3:1), M2 (1:1), M3
s spectrum of the M2 sample. Two types of specific y2+ ions generated
me3-K36me2, green). Quantification was based on the intensity of two
f b1+, b2+, y1+ and y2+ specific ions in a series of tandem mass spectra of
the peak area of two types of y11–y132+ ions
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HPLC and indistinguishable at the MS level, H3K27me3-
K36me2 and H3K27me2-K36me3-containing peptides are
able to produce fragment ions with different masses by
MS/MS (Additional file 1). As indicated in Fig. 1a, y5–13
and b1–9 ions generated by H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides will have dif-
ferent masses and therefore are specific ions for each
isoform. For example, y13 ions with two positive
charges (y132+) generated by H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides have masses
of 667.3886 and 674.3964, respectively. This difference
indicates that we can target the same precursor to gen-
erate the MS/MS spectra, and then may employ the dif-
ferent specific ions to determine the constituent
percentage of the two isoforms. Theoretically, the 3+
precursor should give rise to a series of fragment ions
with 1+ and 2+ charges, while the 4+ precursor can
form 1–3+ charged fragment ions. In the CID fragmen-
tation of bottom-up MS approach, y and b fragment
ions with 1+ and 2+ charges are commonly accepted for
the assignment of peptide sequence [20, 23, 24], so we
target the 3+ precursor of the pentamethylated K27-R40
peptides for subsequent fragmentation and specific ion
analysis.
To test whether we can detect these specific ions, we
performed a LC-MS/MS experiment using the two syn-
thetic peptides, and targeted the 3+ charged precursor
of the pentamethylated H3K27-R40 peptides for subse-
quent fragmentation. Overall, whatever the composition
of single or mixed peptide samples, a series of y ions
with two positive charges (y 2+) were predominantly de-
tected from the 3+ charged precursor, and other frag-
ment ions such as y1+, b1+, and b2+ were not (Fig. 1c, d;
and Additional file 1). Among these, y11–132+ ions were
more intense for the appearance of the proline residue
[25, 26]. These results indicate that the H3K27me3-
K36me2 and H3K27me2-K36me3-containing peptides
are coeluted and cofragmented in the LC-MS/MS
determination.
SIMC quantification of H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides by MS/MS
To examine how we can use these specific ions to know
the constituent percentage of H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides, we performed
LC-MS/MS of a mixture containing an equal amount of
the two peptides (M2). Firstly, we calculated the inten-
sity ratios of individual specific y ion pairs in one single
fragmentation scan. However, even in the scan acquired
when the precursor was strongest, only two types of y82
+ and y10–132+ were detected simultaneously. As shown
in Fig. 1c, m/z values of 588.60, 624.08, and 667.64 cor-
responded to y11–132+ ions for H3K27me3-K36me2-containing peptide, and m/z values of 595.48, 631.03,
and 674.43 corresponded to y11–132+ ions for
H3K27me2-K36me3-containing peptide, respectively.
From the intensity of y11–132+ ion pairs, the constituent
ratios of H3K27me3-K36me2 and H3K27me2-K36me3-
containing peptides were calculated to be 75.74:24.26 for
y112+, 64.06:35.94 for y122+, and 72.67:27.33 for y132+,
respectively. These data were not consistent with the
original compositions (Fig. 1c). In addition, the intensity
ratios of all three y ion pairs varied between different
scans (data not shown). The variation of the intensity of
y11–132+ ions indicates unstable fragmentation efficiency
among individual scans, which makes quantification using
one ion pair in one single scan infeasible.
To examine whether the cumulative intensity of spe-
cific ions from multiple scans can be used to determine
the relative abundance of each peptide, we generated the
intensity curves of y11–132+ ions from multiple scans
along the elution time, as well as all the other 1+ and 2+
charged specific y and b ions (Fig. 1d). Consistent with
the results in the individual scan, not all specific ions
were detectable even in multiple MS/MS scans, and
y11–132+ ions were present predominantly as revealed
by the intensity curves (Fig. 1d). We designated the peak
area of the intensity curve as the cumulative intensity of
each ion and calculated the ratio of each ion pair. The
peak area ratio of each ion pair still varied significantly
(Additional file 2). As displayed in Fig. 1d, the ratio of y112+
ions specific for H3K27me3-K36me2 and H3K27me2-
K36me3-containing peptides was 55.72:44.28, whereas the
ratio was 49.73:50.27 for y122+ and 55.37:44.63 for y132+,
respectively. These results indicated that the quantifica-
tion was also not reliable using the ratio of the cumulative
intensity of one ion pair from multiple scans; even using
the most intense y11–132+ ion pairs, there were still small
variations for the quantification.
To avoid the bias of ion pair selection, we test whether
the sum-up of the cumulative intensities of a series of
specific ions can represent the total amount of each pep-
tide more accurately. After calculating the ratios of b1+,
b2+, y1+, and y2+ specific ions, respectively, we found that
only the ratio from y2+ ions almost matched the real
peptide composition in M2. The mean percentage calcu-
lated from y2+ specific ions (y5–132+) was 52.06:47.94
(Fig. 2g). Moreover, the sum-up peaks of two types of y5–
132+ ions from multiple scans could reflect the amount of
H3K27me3-K36me2 and H3K27me2-K36me3-containing
peptides in M2, and also matched the profile of their pre-
cursors along the elution time (Fig. 2c).
To confirm this conclusion, H3K27me3-K36me2 and
H3K27me2-K36me3-containing peptides were mixed at
different ratios of 1:0, 6:1, 3:1, 1:3, and 0:1, and subjected
to LC-MS/MS. The calculated percentages from the sum-
up peaks of two types of y5–132+ ions from multiple scans
Fig. 2 SIMC quantification of H3K27me3-K36me2 and H3K27me2-K36me3-containing peptides by MS/MS. S1 (K27me2-K36me3) and S2
(K27me3-K36me2) of H3K27-R40me5, and their mixtures M1–M4, were subjected to LC-MS/MS analysis. a–f The intensity of two types of y5–132+
in multiple MS/MS spectra of all samples was summed up and displayed as a SIMC profile. g SIMC quantification of K27me3-K36me2 (green) and
K27me2-K36me3 (red) in H3K27-R40me5. The MS experiment was repeated three times and the error bars represent the SD. SIMC specific ions of
isobaric modification chromatogram
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2.22:97.78, corresponding to the theoretical values of
100:0, 85.71:14.29, 75:25, 25:75, and 0:100, respectively,
with a variance of less than 2.71 % (Fig. 2g). These results
indicated that the constituent percentage of H3K27me3-
K36me2 and H3K27me2-K36me3-containing peptides
could be represented by the sum-up intensity of y5–132+
specific ions from multiple scans. Because the quantitative
peaks depicted the intensity changes of specific ions with
the chromatographic elution of their common precursors,
this method was named SIMC.To ensure that specific ions used for quantification
were accurately assigned, high mass accuracy MS/MS
spectra on Orbitrap were conducted under the same
experimental conditions. The calculated percentages
were 99.84:0.16, 89.01:10.99, 80.32:19.68, 57.41:42.59,
31.61:68.39, and 0.97:99.03, corresponding to the theoret-
ical values of 100:0, 85.71:14.29, 75:25, 50:50, 25:75, and
0:100, respectively, with the variance of less than 0.91 %
(Figure S3G in Additional file 3). As displayed in
Additional files 3 and 4, the cumulative peaks were more
regular and the quantitative percentage from Orbitrap
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H3K27me3-K36me2 and H3K27me2-K36me3-containing
peptides compared with those from LTQ data (Figs. 1d
and 2). However, the values from LTQ were much closer
to the loaded ratio (Figure 2g; and Figure S3G in Additional
file 3). Although Orbitrap can provide a high-resolution
spectrum, the method is insensitive and the data acquisi-
tion is relatively slower, and therefore fewer MS/MS spec-
tra and less specific ions make the SIMC results from
Orbitrap a little further from the loaded ratio (Figure S1B
in Additional file 1, Figure S2B in Additional file 2, and
Additional files 3 and 4). This observation indicated that
the high-accuracy Orbitrap at the first MS level could
minimize the impurity interference, making the relatively
low-accuracy MS/MS spectra by LTQ sufficient for accur-
ate quantification. Also, this result implies that the SIMC
approach can have a wide potential application. Consider-
ing that LTQ is commonly used for MS/MS spectra for
higher sensitivity and scan speed than Orbitrap, we ap-
plied Orbitrap-LTQ MS/MS in this study, with Orbitrap
at the first MS level for the accuracy of the precursor and
LTQ at the MS/MS level for more information of the frag-
ment ions. To further assess the accuracy of the SIMC
method, we performed the crucial validation experiment
in a complex biological background. The M2 sample was
mixed with the tryptic Escherichia coli proteins, which
was known without any histones, and then analyzed by
LC-MS/MS. Finally, the calculated SIMC percentage was
55.20:44.80, closer to the loaded ratio of M2, with a vari-
ance of 1.28 %. This result further validated the robustness
of the SIMC method. Since histones are highly conserved
proteins, the target K27-R40 peptides of H3.1 and H3.2 all
have the same sequence either in yeast or mammalian
cells. Undoubtedly, the pre-existing histone can affect the
result for the same H3 sequence and modification, and
thus it is necessary to avoid the contamination of any
yeast or other mammalian cells.
Effects of tryptic digestion on the quantification of
H3K27me3-K36me2 and H3K27me2-K36me3-containing
peptides
Quantification of the H3K27me3-K36me2 and H3K27me2-
K36me3 modifications requires the generation of a H3
peptide containing both K27 and K36 residues. Trypsin
and Arg-C are the most frequently used proteases in the
bottom-up MS method to produce H3K27-R40 peptides
containing the target modifications. Arg-C specifically
cleaves at the C-terminus of arginine residues and its di-
gestion of H3 can generate the K27-R40 peptide that con-
tains K27 and K36 residues [15]. Trypsin, however, can
cleave both arginine and lysine residues except with an
immediate adjacent proline (P) on the carboxyl side of the
two residues. For the methylated residues, trypsin’s diges-
tion efficiency decreased with the increase of methylgroups. Generally, trypsin can cut monomethylated lysine,
but not dimethylated or trimethylated lysine [23, 27].
Hence, tryptic digestion of histone H3 will also generate
K27-R40 peptides. In addition, compared with the low ef-
ficiency of Arg-C, trypsin can quite effectively digest hypo-
methylated K27-R40 peptides into smaller ones, such as
K27-K36 and S28-R40. As a result, trypsin digestion can
enrich the H3K27-R40 peptides with a high degree of
methylation, including pentamethylation. Considering the
small amount of pentamethylation at H3K27 and H3K36
in the mammalian cells examined, and the priority of
more abundant peptides for MS/MS detection, we ex-
pected to improve the relative abundance of the penta-
methylated K27-R40 peptides by selection of trypsin
instead of Arg-C, so as to acquire as many MS/MS spectra
as possible for SIMC quantification.
To determine whether trypsin digestion may affect the
quantification of H3K27me3-K36me2 and H3K27me2-
K36me3-containing peptides, we synthesized two longer
peptides of H3L20-R52me5, L2 (K27me3-K36me2) and
L1 (K27me2-K36me3), mimicry of the intact histone H3
carrying the two combinatorial modifications (Fig. 3a).
We then mixed the two peptides at different ratios of
6:1, 3:1, 1:1, and 1:3, and performed trypsin digestion.
The digestion time is decided by enzyme efficiency and
target peptides. It is known that trypsin digestion is quite
efficient for histone proteins which are rich in lysine and
arginine residues [28]. Therefore, trypsin partial digestion
has been frequently used for the characterization of his-
tone modification [22, 29, 30]. Since the methyl groups of
lysine can partially hinder the trypsin digestion [28], and
to reduce the possible cleavage for dimethylated or tri-
methylated lysine as much as possible, we performed tryp-
sin in-solution digestions for a short time of 20, 40, and
120 minutes, respectively.
The digested peptide mixtures were first examined using
matrix-assisted laser desorption ionization (MALDI) to
evaluate the digestion efficiency. Although there existed
little insufficient digestion by MALDI in all digested sam-
ples, the content of underdigested products or peptides
longer than H3K27-R40me5 was too low to be detected
by LC-MS/MS. This observation suggests that trypsin has
considerably high efficiency to produce the target penta-
methylated H3K27-R40 peptides. We then detected these
digested samples by LC-MS/MS, and quantified them by
SIMC for the constituent percentage of the isobarically
pentamethylated H3K27-R40 peptides. The calculated per-
centages were similar among different digestion times (20,
40, and 120 minutes, respectively), with average values of
88.84:11.16, 80.01:19.99, 58.73:41.27, and 31.58:68.42, re-
spectively, and were able to reflect the change in the mix-
ing proportion of two long peptides (Fig. 3b; and
Additional file 5). Although there was little overall syn-
chronous decline to the H3K27me2-K36me3 isoform in
Fig. 3 SIMC quantification of tryptic K27me2-K36me3 and K27me3-K36me2-containing H3L20-R52me5 peptides. a Schematic representation of
the isobaric H3L20-R52me5 peptides. b SIMC quantification of K27me3-K36me2 (green) and K27me2-K36me3 (red) in H3L20-R52me5. L1
(K27me2-K36me3) and L2 (K27me3-K36me2) of H3L20-R52me5 with different ratios (3:1, 1:1, 1:3, and 1:6) were digested by trypsin for 20, 40, and
120 minutes, respectively, and were analyzed by LC-MS/MS. The MS experiment was repeated three times and error bars represent the SD
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plained by the original concentration difference of the two
long peptides or the weak preference for H3K27me2-
K36me3 by trypsin digestion (Fig. 3b; Additional file 5).
These results indicate that trypsin digestion does not
affect the SIMC quantification of H3K27me3-K36me2
and H3K27me2-K36me3-containing peptides.
Among the investigated digestion times, the SIMC
values for 40 minutes were a little closer to the theoret-
ical mixture ratio of two H3K27me3-K36me2 and
H3K27me2-K36me3-containing H3L20-R52 peptides
(Fig. 3b). Therefore, we chose this condition for trypsin
digestion of intact histones.
Quantitative analysis of H3K27me3-K36me2 and
H3K27me2-K36me3 in mESCs and differentiated cells
The important regulatory interplay between H3K27me3
and H3K36me3 in the embryonic development suggests
a possible role for other higher methylation states
of these two sites. To determine whether cis-existing
H3K27me3-K36me2 and H3K27me2-K36me3 play a role
in the process, we applied SIMC at MS/MS level com-
bined with SIC at MS level to quantify the two modifica-
tions in mESCs and differentiated cells. Histones from
mESCs (D0) and those induced to differentiate for 2 days
(D2) and 4 days (D4) (Additional file 6) were digested by
trypsin and analyzed by LC-MS/MS.
Through SIC of the precursors at MS level, we calcu-
lated the percentages of H3K27-R40me0–6 (Additional
file 7). As expected, the hypomethylated H3K27-R40me0–3 peptides were decreased, while the pentamethylated
K27-R40 peptides were enriched to 10.77–17.77 % by
trypsin (1:200, 40 minutes) digestion compared with ~5 %
by Arg-C (Additional file 7) [15, 31]. Consistent with the
published data [15, 16], H3K27-R40me5 peptide was more
abundant than H3K27me3-K36me3 in ESCs. Worthy of
note is that no peptides containing K27 and K36 longer
than H3K27-R40 were detected, while only acetylation
coexisting with methylation was observed and present
with one acetyl group on K27 and zero to three methyl
groups on K36 on the H3K27-R40 peptide. The short
H3K27-K36 peptides in the trypsin-digested histone sam-
ples were present with zero to three methyl groups on
K27 and no methyl group on K36, indicating that trypsin
digestion was able to enrich the target pentamethylated
H3K27-R40 peptides for MS quantification.
Using the SIMC approach, the constituent percentages
of H3K27me3-K36me2 and H3K27me2-K36me3 in
mESCs and differentiated cells were calculated. In
mESCs, H3K27me3-K36me2 was the dominant form,
comprising 85.39 % of the pentamethylated H3K27-
R40 population. Upon ESC differentiation, the percent-
age of this modification decreased to 82.19 % at D2
and to 77.25 % at D4, respectively, with a variance of
less than 1.48 % (P = 0.000512, Fig. 4a; and Additional
file 8).
To determine whether the decrease in percentage of
H3K27me3-K36me2 modification was caused by a de-
crease of its own level or by an increase of H3K27me2-
K36me3 level, and also to avoid the influence of tryptic
Fig. 4 Quantification of isobaric H3K27-R40me5 in mESCs and
differentiated cells. a SIMC quantification of K27me3-K36me2
(green) and K27me2-K36me3 (red) isoforms of H3K27-R40me5 in
histones from mESCs (D0) and at differentiation day 2 (D2) and
day 4 (D4) induced by LIF withdrawal. b Relative abundance of each
isoform of H3K27-R40me5 in mESCs and differentiated cells normalized
to the H3D123-R128 peptide. The levels of H3K27-R40me5 and
H3D123-R128 peptides were determined by SIC, and the amount of
K27me2-K36me3 and K27me3-K36me2 isoforms was calculated by
multiplying the total level of the H3K27-R40me5 by SIC and the
constituent percentage of each isoform by SIMC. The MS
experiment was repeated three times and the error bars represent
the SD. ** P <0.01
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smaller ones, the abundance of two isoforms was nor-
malized to a H3D123-R128 peptide (a constitutive and
modification-free tryptic peptide of H3). The results
show that H3K27me3-K36me2 was the dominant penta-
methylated form at H3K27 and H3K36 residues in
mESCs, and the relative abundance of H3K27me3-
K36me2 still significantly decreased upon mESC differ-
entiation, while the level of H3K27me2-K36me3 almost
remained unchanged (Fig. 4b). In addition, the decrease
of H3K27me3-K36me2 isoform was co-occurred with a
global downregulation of K27me3 level observed by
western blot (Additional file 9) [32, 33]. These results indi-
cate that the cis-existence of H3K27me3-K36me2 modifi-
cation is the dominant pentamethylated form at H3K27
and H3K36 residues in mESCs and is downregulated upondifferentiation, suggesting that it may assume the main
regulatory function in ESC differentiation.
The higher methylation states at H3K27 and H3K36
residues play a crucial role in the embryonic develop-
ment [10, 11]. Since the residues of H3K27 and H3K36
are close at the short N-termini of histone H3, they will
more probably act as a combinatorial methylation pat-
tern. The small but significant amount of histone penta-
methylation at H3K27 and H3K36 detected by MS
indicates that the cis-existing H3K27me3-K36me2 and/
or H3K27me2-K36me3 may make a regulatory function
in ESC differentiation [11, 12]. However, it has been
found that the two modifications rarely colocalized at
the same genomic locus, consistent with their opposing
functions [8, 9]. The discordant results relate to the
technology: the antibody-dependent technologies, such
as genome-wide ChIP-Seq and western blot, are good
for one modified state of one single residue, but cannot
reveal the combinatorial modifications of the same histone
molecule; while high-resolution MS is able to provide in-
formation about the combinatorial modifications, and to
usher a new direction for deciphering the “histone code”
[34–36]. For the same sequence and the same number of
modified groups but different sites, the H3K27me3-
K36me2 and H3K27me2-K36me3-containing peptides are
isobarically modified peptides, which remain a big chal-
lenge for MS detection.
To determine the colocalization of two opposing meth-
ylations at H3K27 and K36 residues, we fully used the
characteristics of comigration in RP-HPLC, codetection as
the same precursor, and cofragmentation for two types of
specific ions, and established a simple, label-free, bottom-
up MS method—called SIMC—for the systematic quanti-
fication of H3K27me2-K36me3 or H3K27me3-K36me2
isoforms. As a result, the intensity variation of specific
ions among individual fragmentations could be minimized
by the LC stability. The selection bias of specific ions
could be avoided by a series of specific ions, and thus the
accurate constituent percentage of each isobaric form
could be achieved by the sum-up of the cumulative inten-
sities of a series of specific ions along the multiple con-
secutive scans. Because the SIMC quantification is based
on a series of specific ions for each isobaric modification
from multiple MS/MS spectra, the amount of precursors
is the premise for the acquisition of subsequent MS/MS
spectra. By choice of trypsin digestion, we decreased the
H3K27-R40 peptides with relatively lower methylation de-
gree and enriched our target, the small amount of penta-
methylation at H3K27 and H3K36 in ESCs, which
ensured the acquisition of enough MS/MS spectra for
SIMC quantification. Generally, it is necessary to acquire
enough spectra to depict the outline of the LC peak, so as
to guarantee the chromatogram for the selected ion. In
this study, all SIC levels were calculated from 22 MS
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more than six MS/MS spectra along the LC profile of
the precursor, so that the quantification was stable and
reproducible.
The SIMC is a robust method of quantification. To es-
tablish and test the method, we synthesized two peptides
of H3K27-R40me5, S2 (K27me3-K36me2) and S1
(K27me2-K36me3), and designed six mixing ratios of
the two isoforms (1:0, 6:1, 3:1, 1:1, 1:3, and 0:1), with a
dynamic range from 0 to 100 %. The quantitative values
by SIMC were more than 97.8 % for the pure peptide
samples, and also were able to accurately quantify the
proportion of two peptides in all mixtures, with a vari-
ance of less than 2.71 % (Fig. 2). In this study, although
the relatively small mass tolerance was set for matched
ions (0.4 Da for LTQ data), some interference ions with
low intensity appeared which lowered the calculated ra-
tios for pure synthetic peptides (<100 %). To determine
whether trypsin digestion will affect the SIMC quantifi-
cation of H3K27me3-K36me2 and H3K27me2-K36me3-
containing forms, two long peptides of H3L20-R52me5,
L1 (K27me2-K36me3) and L2 (K27me3-K36me2), were
synthesized and mixed as the short ones (H3K27-R40me5).
After trypsin digestion for 20, 40, and 120 minutes, the
SIMC values were still able to reflect the change in the
mixing proportion of two long peptides, with a variance of
less than 3.20 % (Fig. 3; and Additional file 5). Although
the total levels of H3K27-R40me5 from SIC were only
10.77–17.77 %, the constituent percentages of H3K27me3-
K36me2 and H3K27me2-K36me3 were calculated to be
77.25–85.39:14.61–17.81, with a variance of less than
1.48 % (Fig. 4a; and Additional files 7 and 8).
The sensitivity limit of SIMC was further studied by
diluted M2 samples (Additional file 8). In a 500-fold
dilution of M2 (i.e., 0.15 ng total synthetic peptides
loaded), the SIMC percentage was observed to be
53.30:46.70, with a variance of 1.26 %, indicating that the
sensitivity limit of the SIMC method was 50 pg/μl (100
pmol) for H3K27-R40me5 peptides in our Orbitrap-LTQ
instrument (Additional file 10). Worthy of mention is
that the SIMC approach is based on the tandem spectra,
and therefore the sensitivity of the method mainly depends
on the precursor concentration at the MS level. Obviously,
the SIMC approach is accurate, sensitive, and stable for
systematic quantification of the isobaric H3K27me2-
K36me3 and H3K27me3-K36me2 modifications.
Notably, the peak area ratio of each ion pair for
H3K27me2-K36me3 and H3K27me3-K36me2 isoforms
varied significantly (Additional file 2). Using a series of
main specific ions (y5–132+ ions), we could eliminate
the ion selection variation as much as possible and
achieve accurate and stable quantification (Figs. 2 and
3). Therefore, we can infer that only three discriminative
b and/or y fragment ions for each species were used: b11+,y112+, and y132+ for H3K27me2-K36me3; and b81+, b91+,
and y112+ for H3K27me3-K36me2, the quantification
may be unreliable for the selection of different specific
ions [37]. For the same reason, if the isobaric modifica-
tions are distributed at adjacent residues, the quantifica-
tion may be influenced by the limitation of a specific ion
number.
Considering the principle of the method, it is perceiv-
able that the SIMC can be used to examine the other
isobaric modifications, such as acetylation, and to dissect
the coregulation of more combinatorial modifications,
which will contribute greatly to interpretation of the
“histone code”.Conclusions
By establishing a label-free, bottom-up mass spectrum
method, SIMC, we not only revealed the cis-existence
of H3K27me3-K36me2 in mESCs, but also suggested
that this combinatorial histone modification may assume
a specific regulatory function during differentiation.Additional files
Additional file 1: Figure S1. Showing the strongest tandem mass
spectra of S1 (H3K27me2-K36me3), S2 (H3K27me3-K36me2), and M2
(containing an equal amount of S1 and S2 peptides) by LTQ A and by
Orbitrap B. (DOCX 123 kb)
Additional file 2: Figure S2. Showing quantification of H3K27me3-
K36me2 and H3K27me2-K36me3-containing peptides in M2 based on the
peak area of individual specific ion by LTQ A and by Orbitrap B. All 1+
and 2+ charged b1–9 and y5–13 specific ions were examined in multiple
tandem mass spectrum of M2, a mixture containing an equal amount of
the two peptides of H3K27-R40me5, S1 (K27me2-K36me3) and S2
(K27me3-K36me2). The peak area of the intensity curve in Fig. 1d and
Additional file 4 was designated as the cumulative intensity of each ion
to calculate the ratio of each ion pair. (DOCX 204 kb)
Additional file 3: Figure S3. Showing SIMC quantification of
H3K27me3-K36me2 and H3K27me2-K36me3-containing peptides by
Orbitrap MS/MS. Two synthetic peptides S1 (K27me2-K36me3) and S2
(K27me3-K36me2) of H3K27-R40, and their mixtures M1–M4 were subjected
to LC-MS/MS analysis. The intensity of two types of all specific y2+ ions in
multiple tandem mass spectra of all peptide samples from Orbitrap was
summarized and showed as a SIMC profile A–F. G SIMC quantification of
K27me3-K36me2 and K27me2-K36me3 in S1, S2, and M1–M4 samples from
Orbitrap data. Constituent percentages of two isoforms of H3K27-R40me5
were indicated with different colors, K27me2-K36me3 in red and K27me3-
K36me2 in green. The MS experiment was repeated three times and error
bars represent the SD. (DOCX 260 kb)
Additional file 4: Figure S4. Showing the intensity of two types of b1+,
b2+, y1+, and y2+ specific ions in a series of tandem mass spectra of M2
by Orbitrap displayed as a chromatographic profile. Quantification was
based on the peak area of two types of y11–132+ ions. (DOCX 90 kb)
Additional file 5: Figure S5. Showing SIMC quantification of
H3K27me3-K36me2 and H3K27me2-K36me3-containing peptides
digested by trypsin. Two longer synthetic peptides of H3 L20-R52me5, L1
(K27me2-K36me3) and L2 (K27me3-K36me2), were mixed with different
ratios (M1–M4), and digested with trypsin for 20, 40, and 120 minutes,
respectively. The results for SIMC quantification of K27me3-K36me2 and
K27me2-K36me3 in M1 A–C, M2 D–F, M3 G–I, and M4 J–L samples
displayed as curves. (DOCX 249 kb)
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undifferentiated (D0) and differentiated mouse ES cells at day 2 (D2) and
day 4 (D4). B Quantitative RT-PCR analysis of pluripotency (Oct4 and
Nanog) and differentiation (Fgf5, T, Sox1 and Gata4) markers along ESC
differentiation. Experiment was repeated three times and error bars
represent the SD. (DOCX 997 kb)
Additional file 7: Figure S7. Showing SIC quantification of H3K27-
R40me0-6 peptides in undifferentiated (D0) and differentiated mESCs (D2
and D4). Through SIC of the precursors at MS level, the percentages of
H3K27-R40me0-6 were calculated in Arg-C A and trypsin B digested
samples, respectively. (DOCX 72 kb)
Additional file 8: Figure S8. Showing SIMC quantification of two
isoforms of H3K27-R40me5 in mESCs and differentiated cells for three
repeated experiments. The isoforms were labeled with different colors,
and displayed as curves, K27me2-K36me3 in red and K27me3-K36me2 in
green, respectively. (DOCX 189 kb)
Additional file 9: Figure S9. Showing western blot analysis of
H3K27me3 levels in undifferentiated (D0) and differentiated ESCs (D2 and
D4). H3 was used as the loading control. (DOCX 116 kb)
Additional file 10: Figure S10. Showing SIMC quantification of S1
(K27me2-K36me3) and S2 (K27me3-K36me2) in a series of diluted
solutions. A mixture containing S1 and S2 (50 wt%:50 wt%, 25 ng/μl) was
diluted 10, 50, 100, and 500 times (10×, 50×, 100×, and 500×) by ddH2O,
respectively. Constituent percentages of K27me2-K36me3 (red) and
K27me3-K36me2 (green) were detected. The MS experiment was repeated
three times and error bars represent the SD. (DOCX 79 kb)
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